Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.
Title | Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. |
Publication Type | Journal Article |
Year of Publication | 2006 |
Authors | Athyros, V. G., Mikhailidis D. P., Didangelos T. P., Giouleme O. I., Liberopoulos E. N., Karagiannis A., Kakafika A. I., Tziomalos K., Burroughs A. K., & Elisaf M. S. |
Journal | Curr Med Res Opin |
Volume | 22 |
Issue | 5 |
Pagination | 873-83 |
Date Published | 2006 May |
ISSN | 0300-7995 |
Keywords | Anti-Obesity Agents, Atorvastatin, Diet, Fat-Restricted, Drug Therapy, Combination, Dyslipidemias, Fatty Liver, Female, Fenofibrate, Heptanoic Acids, Humans, Hypolipidemic Agents, Lactones, Male, Metabolic syndrome, Middle Aged, Orlistat, Prevalence, Prospective Studies, Pyrroles, Risk Factors, Treatment Outcome, Ultrasonography, Weight Loss |
Abstract | BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). There is no established treatment for NAFLD. |
DOI | 10.1185/030079906X104696 |
Alternate Journal | Curr Med Res Opin |
PubMed ID | 16709309 |